Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants

G. Klinger, Gideon Koren

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

QUESTION One of my patients, a 36-year-old, who has had three pregnancies and two live births, delivered her third baby at 32 weeks' gestation. Her first pregnancy was complicated by premature labour, which led to delivery at 30 weeks' gestation. She received antenatal phenobarbital before the first delivery because it was considered proven therapy for preventing intraventricular hemorrhage in preterm infants. I would like to know why it is no longer routinely used. ANSWER Cumulative results from recent studies have failed to confirm the initial impression of effectivenes of antenatal phenobarbital. It: is no longer recommended when preterm delivery is anticipated.

Original languageEnglish
Pages (from-to)1285-1286
Number of pages2
JournalCanadian Family Physician
Volume46
Issue numberJUN.
StatePublished - Jun 2000

Fingerprint

Dive into the research topics of 'Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants'. Together they form a unique fingerprint.

Cite this